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Abstract
Background: Image-quality assessment is a fundamental step before clinical evaluation of magnetic resonance images.
The aim of this study was to introduce a visual scoring system that provides a quality control standard for arterial spin
labeling (ASL) and that can be applied to cerebral blood flow (CBF) maps, as well as to ancillary ASL images.
Methods: The proposed image quality control (QC) system had two components: (1) contrast-based QC (cQC),
describing the visual contrast between anatomical structures; and (2) artifact-based QC (aQC), evaluating image quality of
the CBF map for the presence of common types of artifacts. Three raters evaluated cQC and aQC for 158 quantitative
signal targeting with alternating radiofrequency labelling of arterial regions (QUASAR) ASL scans (CBF, T1 relaxation rate,
arterial blood volume, and arterial transient time). Spearman correlation coefficient (r), intraclass correlation coefficients
(ICC), and receiver operating characteristic analysis were used.
Results: Intra/inter-rater agreement ranged from moderate to excellent; inter-rater ICC was 0.72 for cQC, 0.60 for aQC, and
0.74 for the combined QC (cQC + aQC). Intra-rater ICC was 0.90 for cQC; 0.80 for aQC, and 0.90 for the combined QC.
Strong correlations were found between aQC and CBF maps quality (r = 0.75), and between aQC and cQC (r = 0.70). A QC
score of 18 was optimal to discriminate between high and low quality clinical scans.
Conclusions: The proposed QC system provided high reproducibility and a reliable threshold for discarding low quality
scans. Future research should compare this visual QC system with an automatic QC system.
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Key points
 ASL quality control guidelines and standards of
acceptance are needed for clinicians
 Visual quality control score is able to select clinically
useful scans
 This quality control shows reasonable
reproducibility and reliability
 Quality control can be applied to various ASL
sequences
Background
Arterial spin labeling (ASL) is a non-invasive magnetic res-
onance imaging technique that uses magnetically labelled
blood water as an endogenous diffusible tracer to quantify
cerebral blood flow (CBF) [1]. Because of the tight coupling
between brain perfusion and neuronal health, ASL has
shown to be an indispensable tool to study brain function
in vivo [2–4]. Its non-invasiveness and the lack of an inject-
able tracer allows longitudinal monitoring of disease pro-
gression and treatment efficacy [5].
For the translation of ASL to clinical practice, a wide
range of significant developments were performed [6].
Image quality has been improved [7], acquisition times
have been reduced [8] and the reliability and reproducibil-
ity of ASL perfusion images has been established for mul-
tiple centres with different scanners and sequences [9, 10].
Standardised acquisition methods were agreed upon [1],
physiological perfusion confounders were reviewed [11]
and standardised image processing methods are developed
[12, 13]. One lacking step for enabling translation of ASL
to clinical practice and clinical trials is the development
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and validation of standardised quality control (QC) guide-
lines [1].
Typically, ASL provides CBF as a single measure of
perfusion. However, ASL techniques can be modified to
acquire CBF images at multiple post-labelling delays.
This offers more information about the labelled bolus
and its arrival to the tissue, providing more comprehen-
sive haemodynamic parameters [14, 15]. One of these
techniques is the quantitative signal targeting with alter-
nating radiofrequency labelling of arterial regions (QUA-
SAR) [16]. In addition to CBF maps, QUASAR acquires
several other ancillary parametric maps in the same
resolution and space as the ASL CBF image [14, 16].
First, R1 maps are derived from the Look-Locker multi-
inversion time scheme, representing the longitudinal re-
laxation rate of the brain tissue. It has contrast similar
to a T1-weighted image and, therefore, carries relatively
detailed anatomical information. Arterial blood volume
(aBV) maps are similar to low-resolution angiography
maps, whereas arterial transit time (ATT) maps show
the time necessary for the labelled blood to flow from
the labelling slab to the vascular compartment of the im-
aging voxel. ATT maps can be useful to demonstrate the
regions of prolonged transit time such as in steno-occlu-
sive diseases [17]. In the normal brain, boundaries be-
tween the territories of the anterior, middle, and
posterior cerebral arteries (watershed areas) have longer
ATT than the core of these perfusion territories, thereby
delineating areas prone to borderzone or watershed
stroke [17].
This study introduces a visual QC system for the clin-
ical evaluation of ASL perfusion maps. This visual QC
system consists of two components: (1) a contrast com-
ponent that indicates the image contrast between ana-
tomical structures; and (2) an artifact component that
scores the presence of image artifacts that degrade image
quality, as previously proposed [1]. For a wide range of
applicability, this visual QC system was not only devel-
oped for CBF maps, but also for other ancillary images
that can potentially be acquired. The visual QC was
evaluated in patients with a range of diseases, as well as
in healthy volunteers.
Methods
Participants and study design
Data for this study originated from several previous studies
regarding stroke, multiple sclerosis, QUASAR reproducibil-
ity [9, 18–21] as well as brain involvement in human im-
munodeficiency virus (HIV) infection and ECST-2 (Second
European Carotid Surgery Trial, http://s489637516.website-
home.co.uk/ECST2/index2.htm); these latter performed at
University College of London Hospitals (UCLH) and never
published. QUASAR ASL scans of 158 subjects (age 47 ±
17.6, mean ± standard deviation; range of 18–98 years; 81
males) from six Philips 3T scanners from five different cen-
tres were included. The mixed study population consisted
of 60 healthy volunteers (age 33.7 ± 8.9, mean ± standard
deviation; range of 18–65 years; 34 males) from the QUA-
SAR reproducibility study [1, 18, 20], 48 multiple sclerosis
patients, 41 stroke patients and nine HIV-positive subjects.
All studies were ethically approved by the Research Ethics
Committees of studies used in this retrospective analysis
(the multiple sclerosis patient study was approved by the
Central London Research Ethics Committee number 09/
H0715/45; the European Carotid Surgery Trial 2 (ECST2)
by the National Research Ethics Service Committee – East
of England, ref.: 11/EE/0347; the HIV patient study by the
South East Coast – Surrey Research Ethics Committee 12/
LO/0073; the QUASAR Reproducibility Study by the
Singapore National Healthcare Group’s Domain Specific
Review Board DSRB-A-036). Written informed consent
was provided by all subjects.
QUASAR image acquisition and processing
All imaging was performed on Philips 3T scanners
(Achieva, Philips Healthcare, Best, The Netherlands) using
the following QUASAR pulse sequence parameters: repe-
tition time / echo time = 4000/22.5 ms; 13 inversion times
between 40 ms and 3640 ms with an interval of 300 ms,
flip angle 35°; field-of-view 240 × 240 mm2; matrix 64 ×
64; seven slices of 6-mm thickness with a 2-mm gap,
resulting in a 3.75 × 3.75 × 8 mm3 resolution. Label slab
thickness was 150 mm; label gap 15 mm; vascular
crushers set at 3 cm/s. All data were processed with QUA-
SAR software [9, 16] written in Interactive Data Language
(IDL 8.2, ITT Visual Information Solutions, Boulder, CO).
Image processing and quantification were performed ac-
cording to recent consensus [1]. All images were evaluated
in native ASL space using ImageJ (National Institutes of
Health, Bethesda, MD, USA, v. 1.52e) [22].
Visual QC
The visual QC score composed of two parts. The
contrast-based QC (cQC) described the visual contrast
between anatomical structures and it can be used not
only for CBF maps but also for the ancillary parametric
maps (R1, aBV, ATT). The scores had a value between 0
and 2, with three items for each cQC maps, with a max-
imal value of 6 per map (i.e. CBF, R1, aBV, and ATT
maps), totalling into 24 for these four cQC maps. The
artifact-based QC (aQC) evaluated image quality with
respect to common artifacts that can affect ASL CBF
maps, and was only used for the CBF maps. Each of the
four aQC items (motion, signal drop, distortion, and
bright spots, as described below) had a value between 0
and 2, totalling a max of 8. The total QC score then had
a maximum value of 24 + 8 = 32 (Table 1).
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Contrast-based QC
For each image, the contrast visibility of three items was
assessed (Table 1). Each item was scored from 0 to 2, as
follows: clearly visible contrast (score 2), unclear con-
trast (score 1) or no visible contrast (score 0). The total
score of each map (CBF, R1, aBV, ATT) had a maximum
value of 6, for a maximum achievable cQC score value
of 24. Higher scores equate to higher image contrast.
For the CBF and R1 maps, the three cQC items were
the cortical grey matter, deep grey matter (i.e. basal
ganglia and thalami), and grey matter (GM) to white
matter (WM) differentiation. For the aBV maps, these
were the contrast visibility of the three major intracere-
bral arteries: bilateral anterior, middle, and posterior
cerebral arteries. These arteries appear as high-intensity
vessels on the aBV maps. In the case of low scores, the
anatomical images were reviewed to exclude arterial oc-
clusion. For the ATT maps, the three cQC items investi-
gated were the anterior and posterior superficial
watershed areas, and the deep watershed area, which lie
at the borders of major arterial territories [23]. These
watershed areas were evaluated as prolonged ATT times
on the ATT maps (Fig. 1).
Artifact-based QC
Four types of artifacts were assessed on the CBF maps:
head motion, signal drop, geometric distortion, and
macro-vascular bright spots (Fig. 2). Each item was
scored from 0 to 2: no artifacts (score 2), moderate arti-
facts (score 1) or severe artifacts (score 0). The max-
imum achievable aQC score was 8, with higher scores
equating to fewer image artifacts. Motion artifacts were
detected as a hyperintensity rim around the CBF maps
(Fig. 2a), which are due to the subtractive nature of ASL.
Signal drop (Fig. 2b) and geometric distortion (Fig. 2c)
are the consequence of echo-planar imaging magnetic
susceptibility at brain tissue-bone-air interface (suscepti-
bility artifacts). Signal drop occurs frequently in the
medial temporal cortex near the mastoid air cells at the
base of the skull, as well as in the orbitofrontal cortex
near the paranasal sinuses [24]. Some signal drop at the
base of the skull is inevitable, and this was only scored
when excessive aeration of the sinuses or petrous bone –
defined as hyperpneumatisation – degraded the image
contrast. Geometric distortion was defined as alterations
of the outer contour of the image.
Macro-vascular artifacts are recognised as bright spots,
due to voxels with a large aBV containing residual labelled
blood in the large vessels. A typical example of a macro-
vascular artifact of the middle cerebral artery is shown on
the right in Fig. 2d. Macro-vascular artifacts or bright
spots were defined as irregular, asymmetrical, vessel-
shaped, high-intensity clusters, combined by a surround-
ing or distal, low-intensity area. Visual or auditory activa-
tion can mimic bright foci/spots in the primary visual and
auditory cortices [24]. However, these are more often ob-
served as a larger homogeneous area, often bilateral, and
not accompanied by a surrounding or distal, low-intensity
region [25]. Noise and motion may also present as bright
spots [24, 25]. Care was taken to differentiate these causes
of bright spots, by the above radiological image features
as well as by the knowledge of vascular anatomy, al-
though the latter can differ between subjects.
Table 1 Items evaluated for the visual quality control of ASL
images
Evaluation of CBF maps
Contrast component
Grey matter (0–2)
Grey/white matter differentiation (0–2)
Basal ganglia and thalami (0–2)
Subtotal (0–6)
Artifact component
Motion (0–2)
Signal drop (0–2)
Distortion (0–2)
Bright spots and areas (0–2)
Subtotal (0–8)
Grand total (0–14)
Evaluation of ancillary maps (QUASAR-specific)
Contrast
R1
Grey matter (0–2)
Grey/white matter differentiation (0–2)
Basal ganglia and thalami (0–2)
Subtotal (0–6)
aBV
Anterior cerebral arteries (0–2)
Middle cerebral arteries (0–2)
Posterior cerebral arteries (0–2)
Subtotal (0–6)
ATT
Anterior watershed area (2)
Posterior watershed area (2)
Deep watershed area (2)
Subtotal (0–6)
Grand total (0–18)
A higher score means a better contrast or less artifacts. Range of scores within
parentheses. ASL arterial spin labeling, CBF cerebral blood flow, QUASAR
quantitative signal targeting with alternating radiofrequency labelling of
arterial regions, R1 longitudinal relaxation rate, aBV arterial blood volume, ATT
arterial transit time
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Raters
All maps were independently evaluated within the same
time period by three neuroradiologists, S.F. F.P. and
B.G. with, respectively 7, 10, and 17 years of experience.
Before rating, the raters had a training session to agree
on how to score image contrast and artifacts. S.F. per-
formed the rating of all data twice with an interval of
2 months, to assess the intra-rater agreement. Two
raters, F.P. and S.B. independently performed an evalu-
ation of the CBF maps to determine whether these were
clinically usable or not. A senior neuroradiologist
(28 years of experience), R.J. revised any disagreement
and provided the final decision as to whether the scans
were clinically usable or not. This binary evaluation
was used as a reference to define a ‘clinically valid’
threshold using the receiver operating characteristic
(ROC) analysis.
The scoring performed by the rater F.P. was only in-
cluded in the agreement analysis, being excluded from
the ROC analysis because she had participated in the
binary classification that was used as a reference.
Statistical analysis
The Spearman correlation coefficient (r) was used to
investigate the relationship between image contrast and
artifact scores (cQC and aQC). Intraclass correlation co-
efficients (ICC) were calculated to determine the levels
of inter- and intra-rater agreements. ICC values were
interpreted according to the following categorisation: 0
≦ unusable < 0.2 ≦ poor < 0.4 ≦ fair < 0.6 ≦ good < 0.8 ≦
excellent ≦ 1.0 agreement [26, 27].
CBF, cQS, aQS, and total visual QC ROC curves were
plotted with different thresholds to assess their perform-
ance in differentiating clinically usable and unusable
ASL scans. Optimal thresholds were defined as those
resulting in the maximum area under the curve (AUC).
Sensitivity, specificity, positive and negative predictive
Fig. 1 The cerebral blood flow (CBF) and T1 relaxation rate (R1) maps in the top row show an example of good contrast between the white
matter and the cortical and subcortical grey matter: caudate nucleus head and body (arrowheads), thalamus (asterisk), white matter (arrow), grey
matter (open-headed arrow). The arterial blood volume (aBV) maps illustrate the larger arterial volume corresponding to the anterior (triple
arrow), middle (double arrow) and posterior cerebral (open arrow) arteries. The arterial transit time (ATT) maps show the areas of prolonged ATT
in the superficial (asterisks) and deep (triple arrows) watershed areas
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values for differentiating between usable and non-usable
ASL scans were also calculated.
Results
Boxplots in Fig. 3 illustrate the QC scores of the three
raters individually for each of the maps. R1 maps consist-
ently showed the highest image contrast (median = 6).
The CBF cQC and total QC scores correlated strongly
with the aQC (r = 0.75, p < 0.001 and r = 0.70, p < 0.001,
respectively, Table 2). Scans with poor cQC on the aBV
maps also scored low on the CBF and ATT maps.
Whereas the total cQC correlated strongly with mo-
tion artifacts (r = 0.62, p < 0.001), it correlated weakly
with signal drop and geometric distortion artifacts (r =
0.29, p = 0.001 and r = 0.22, p = 0.002), respectively. The
macro-vascular bright spots artifacts correlated moder-
ately with the cQC (r = 0.48, p < 0.001).
Intra- and inter-rater agreement
The neuroradiologists agreed in 123 maps and disagreed
in 35 maps. The intra-rater agreement was high for cQC
(ICC = 0.90), for aQC (ICC = 0.80), and for the combined
QC (ICC = 0.90, Table 3). The inter-rater ICC was good
for cQC (ICC = 0.72), for aQC (ICC = 0.60), and for the
combined QC (ICC = 0.74).
Figure 4 shows intra- and inter-rater Bland-Altman
plots for the combined QC score. Intra-rater, the 95%
limits of agreement were ± 5.5 points, which equates to a
within-subject coefficient of variation of 29.0% for a
mean score of 19 points. While the mean difference be-
tween raters was less than 1.5 points in all three com-
parisons, the 95% limits of agreement for inter-rater
variation (Fig. 4a, b, and c) were ± 8 points in all cases.
This equates to a within-subject coefficient of variation
of 42.1% for a mean score of 19 points.
Diagnostic quality
Table 4 shows the sensitivity and specificity for the de-
tection of clinically usable and non-usable ASL scans,
using the cQC for the CBF images only. They were: 79
and 93%, respectively, for the CBF cQC at threshold
value of 4/6; 85 and 80% for the total cQC at threshold
value of 15/24; 87 and 76% for aQC at threshold value
of 4/8; 90 and 80% for the total QC for threshold value
of 18/32 (Table 4).
Whereas the CBF cQC had the highest AUC, 0.91
(0.88–0.94 95% confidence interval (CI)), the aQC had
the lowest AUC, 0.88 (0.82–0.90 95% CI). AUC for the
total cQC was 0.89 (0.83–0.91 95% CI) and 0.90 for the
total QC (0.86–0.93 95% CI) (Fig. 5).
Discussion
The main finding of this study is that the developed vis-
ual QC score system showed robustness within and be-
tween raters. The neuroradiologists felt this to be a
helpful and easy-to-use rating system that provides an
image quality indication before using ASL for any clin-
ical or research assessment.
We provide several threshold scores as guidelines to
determine whether or not the ASL image is of diagnostic
quality. For the combined QC as used for QUASAR, a
threshold of 18 seemed to be a robust choice. The fact
that the CBF cQC score had a slightly higher perform-
ance can be explained by the fact that the reference for
diagnostic usability was derived mainly from the CBF
maps. Hence, for clinical single post-labelling delay
pseudo-continuous ASL sequences, a CBF cQC thresh-
old of 4 can be used as a diagnostic quality guideline. A
CBF cQC score of 4 had the highest AUC (90%), and
Fig. 2 Cerebral blood flow images containing examples of artifacts:
a motion artifacts are observed as pseudo-perfusion hyperintensity
rings (red arrows), b signal drop in the inferior orbitofrontal region
(green arrows), c geometric anterior-posterior distortion (red arrows),
d bright spots depicting macro-vascular artifacts from the posterior
cerebral artery behind the thalamus (1) and in the cortex (2, green
arrows). Note that the 0 signal drop image is a 3D spiral image, for a
better contrast on how the inferior orbitofrontal perfusion should
appear without signal drop.
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this threshold predicted clinical usability with specificity
and sensitivity of 90 and 75%, respectively.
The high correlation between cQC and aQC may not
be surprising, as image artifacts can obscure perfusion
contrast. Interestingly, the motion aQC had the highest
correlation with the cQC. This fits with a previous simu-
lation study [28], which showed that motion had a
smoothing effect on the contrast between GM and WM
CBF across the brain. Motion artifacts are known to
have a high impact on ASL image quality, due to the
subtractive nature of the technique [1]. This is particu-
larly emphasised for ASL sequences without background
suppression, as was the case for QUASAR in this study.
The lack of a correlation between signal drop aQC and
cQC could be explained by the fact that this susceptibility
artifact is inevitable in several clinical magnetic resonance
imaging (MRI) acquisitions, and are well-known and toler-
ated by radiologists. While its extent may vary largely
between subjects because of difference normal variants of
sinuses and air cavities, the locations and appearance of
these artifacts are well-known. This led also to the prag-
matic choice of accepting a slight signal dropout near the
base of the skull as clinically usable, and normal. The
other result of susceptibility artifacts − geometric distor-
tion – also did not correlate with cQC. Geometric distor-
tion is relatively mild in ASL compared to other advanced
techniques, such as functional MRI and diffusion tensor
imaging, as the readout length is typically shorter than in
the latter techniques [29]. Moreover, this distortion does
not necessarily change image contrast.
The raters had a good visual training regarding the
main physiological and vascular anatomy variations ex-
pected in patients, so they did not report any particular
difficulties to differentiate between them and the noise-
or motion-related causes of bright spots. There was a
moderate positive correlation between the bright spot
aQC score and the general cQC (r = 0.48, p = 0.001).
Notably, although the primary goal of our study was
to provide guidelines for radiologists to accept or discard
Fig. 3 Visibility scores for each of the individual raters and all the data from the three raters. The T1 relaxation rate (R1) map has the highest score,
median score of 6 averaged for all raters
Table 2 Spearman’s correlation coefficient between the first (QC)
and second (items) columns for raters individually (columns 3,4
and 5) and for all raters in the last column
QC Item Rater 1 Rater 2 Rater 3 All
cQC CBF 0.85 0.78 0.60 0.75
cQC R1 0.59 0.46 0.56 0.48
cQC aBV 0.57 0.40 0.36 0.42
cQC ATT 0.48 0.56 0.36 0.46
QC Total cQC 0.80 0.74 0.60 0.70
aQC Motion 0.70 0.56 0.65 0.62
aQC Signal dropout 0.24 0.28 0.44 0.29
aQC Distortion 0.21 0.25 0.22 0.22
aQC Bright spots 0.58 0.63 0.26 0.48
aBV arterial blood volume ATT arterial transit time, CBF cerebral blood flow,
aQC artifact-based quality control, cQC contrast-based quality control, R1 T1
relaxation rate
Table 3 Intra- and inter-rater intraclass correlation coefficient(ICC)
values
ICC CBF R1 aBV ATT cQC aQC Total QC
Intra-rater 0.87 0.84 0.77 0.86 0.90 0.80 0.90
Inter-rater 0.70 0.50 0.45 0.63 0.72 0.60 0.74
aBV arterial blood volume, aQC artifact-based quality control, ATT arterial
transit time, CBF cerebral blood flow, cQC contrast-based quality control, R1 T1
relaxation rate
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an individual ASL scan based on visual QC, this scoring
system can also be used as a teaching tool for neuroradi-
ologists that are not familiar to ASL, to differentiate arti-
facts from perfusion changes.
The visual differentiation between normal anatomical
variants and acquisition artifacts can be difficult. We ac-
knowledge several conditions where pathology is known
to simulate acquisition artifacts. A frequently occurring
example is the signal drop due to a pathologically pro-
longed bolus arrival time. A more rare example is that
the bright areas are explained by a pathological
Fig. 4 Bland-Altman plots illustrate inter (1–3) and intra-rater (4) variation of the combined score measurements. Red dashed lines are 95% CI of
limits of repeatability, and the blue line is the mean difference.
Table 4 Performance of CBF, QC, cQC, and aQC
CBF cQC Total QC Total cQC aQC
Score 4/6 19/32 15/24 4/8
Sensitivity (%) 75 87 88 90
Specificity (%) 90 73 73 68
PPV (%) 91 84 83 81
NPV (%) 70 78 79 82
aQC artifact-based quality control, cQC contrast-based quality control, CBF
cerebral blood flow, NPV negative predictive value, PPV positive predictive
value, QC quality control
Fig. 5 Receiver-operator characteristic (ROC) curves of cerebral
blood flow (CBF) cQC, contrast-based quality control (cQC), artifact-
based QC (aQC) and total QC. The areas under the curve for these 4
parameters are, respectively: 0.90, 0.89, 0.87, and 0.86
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arteriovenous shunt [30]. In the first case, the typical
anatomical vessel distribution of the signal drop areas
can suggest the presence of an unknown extracranial
vessel stenosis, while in the second one, the serpiginous
shape of the bright areas, the bright signal in the main
drainage veins and sinuses can indicate the presence of
an arteriovenous shunt. The corresponding conventional
anatomical MRI images can show a cluster of enlarged
vessels in the latter case, due to an arteriovenous malfor-
mation, or a thin or absent flow void in T2- and
T2*-weighted gradient-echo sequences of the intracra-
nial portion of vessels, in case of a stenosis or occlusion.
In doubtful cases, we suggest a pragmatic approach of
taking into account the corresponding anatomical im-
ages and comparing them to the ASL maps to avoid
treating physiological changes as image artifacts.
This study suffers from several potential limitations.
Both the scoring system and the diagnostic usability
which was used as a reference, are subjective. Future
work may compare this clinical visual scoring system
with existing parametric scoring systems, which may be
more objective [31–34]. However, these parameters are
sensitive to both instrumental and (patho-)physiological
changes, making them less reliable for clinical use. This
is especially important in the case of ASL, because its
signal-to-noise ratio is directly related to CBF and other
physiological alterations, such as haematocrit or oxygen-
ation changes, hence clinical knowledge is required to
distinguish instrumental artifacts from artifacts that are
disease-related and inevitable [35]. Future work should
investigate the combined performance of a visual and
parametric QC in clinical applications of ASL.
On the other hand, the fact that image contrast and
the presence of motion and vascular artifacts are
disease-related in ASL, is a potential limitation to our
visual QC as well. To this end, we included both ASL
scans from patients and healthy controls. Although path-
ology could also affect our scoring, these changes are
often focal compared to a more widespread acquisition-
related quality decrease. Nevertheless, there remain
cases where the differentiation between acquisition- or
pathology-related quality decreases are difficult to assess,
e.g. the GM-to-WM contrast loss in labelling asymmetry
could appear the same as in a unilateral infarct. To dif-
ferentiate these, we recommend to evaluate the anatom-
ical MR images and perform a double comparison
between them, as suggested above.
We found that the scan quality in patients ap-
peared visually inferior to that of healthy controls,
which was correlated to motion and a loss of image
contrast, and vascular artifacts. Nevertheless, the
majority of patient scans were considered clinically
usable in the binary classification. However, it should
be noticed that the poorer cQC and aQC scores for
ASL scans from patients need to be accepted to a
certain degree.
Another limitation to this study is that we only tested
our scoring system in QUASAR scans with a two-di-
mensional (2D) echo-planar readout, which are not the
type of scans recommended by the white paper [1]. Al-
though image contrast and artifacts are expected to ap-
pear similar on other ASL sequences with a 2D echo-
planar readout, they may differ with three-dimensional
(3D) ASL readouts. The main difference is a lower ef-
fective spatial resolution for the 3D readouts that are
used in ASL: 3D spiral and 3D gradient and spin-echo,
mostly because of their wider acquisition point-spread
function [36, 37]. These sequences still have a lower
GM-to-WM contrast, less visibility and higher sensitivity
for motion artifacts. Furthermore, these 3D sequences
have a lower degree of geometric distortion and signal
dropout, especially the 3D spiral sequence.
In conclusion, the proposed scoring system provides a
robust visual quality control for QUASAR ASL images.
The scoring system has demonstrated the ability to
select clinically useful scans and shows reasonable repro-
ducibility and reliability. Our results encourage future
efforts to expand on our quality control guidelines for
this growing technique.
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